Factors Affecting Reduction of Reference Endotoxin Standard Activity Caused by Chelating Agent/Detergent Matrices: Kinetic Analysis of Low Endotoxin Recovery

References

1. 1.↵
   Chapter <85> Bacterial Endotoxins Test. In The United States Phamacopeia 40; The United States Pharmacopeial Convention: Rockville, MD, 2017, 163–169.
2. 2.↵
   Evaluation and Recommendation of Pharmacopoeial Tests for Use in the ICH Regions on Bacterial Endotoxins Test General Chapter Q4B Annex 14, ICH Harmonised Tripartite Guideline, ICH Expert Working Group, 2012.
3. 3.↵
   1. Rietschel E. T.

   1. Galanos C.,
   2. Luderitz O.

   Lipopolysaccharide: Properties of an Amphipathic Molecule. In Handbook of Endotoxin: Chemistry of Endotoxin; Rietschel E. T., Ed.; Elsevier Science Publishers B. V.: Amsterdam, 1984; Vol. 1, pp 46–58.

   OpenUrl
4. 4.↵
   1. Poole S.,
   2. Dawson P.,
   3. Gaines Das R. E.

   Second International Standard for Endotoxin: Calibration in an International Collaborative Study. J. Endotoxin Res. 1997, 4 (3), 221–231.

   OpenUrl
5. 5.↵
   1. Nowtony A.

   Molecular Aspects of Endotoxic Reactions. Bacteriol. Rev. 1969, 33 (1), 72–98.

   OpenUrlFREE Full Text
6. 6.↵
   1. Nowtony A.,
   2. Spitzer J. J.,
   3. Zieglar E. J.

   1. Rietschel E. T.,
   2. Brade L.,
   3. Holst O.,
   4. Kulshin V. A.,
   5. Lindner B.,
   6. Moran A. P.,
   7. Schade U. F.,
   8. Zahringer U.,
   9. Brade H.

   Molecular Structure of Bacterial Endotoxin in Relation to Bioactivity. In Cellular and Molecular Aspects of Endotoxin Reactions; Nowtony A., Spitzer J. J., Zieglar E. J., Eds.; Elsevier Science Publishers B. V.: Amsterdam, 1990; pp 15–32.
7. 7.↵
   1. Gutsmann T.,
   2. Schromm A. B.,
   3. Brandenburg K.

   The Physicochemistry of Endotoxins in Relation to Bioactivity. Int. J. Med. Microbiol. 2007, 297 (5), 341–352.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Ribi E.,
   2. Anacker R. L.,
   3. Brown R.,
   4. Haskins W. T.,
   5. Malmgren B.,
   6. Milner K. C.,
   7. Rudbach J. A.

   Reaction of Endotoxin and Surfactants. I. Physical and Biological Properties of Endotoxin Treatment with Sodium Deoxycholate. J. Bacteriol. 1966, 92 (5), 1493–1509.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Mueller M.,
   2. Lindner B.,
   3. Kusumoto S.,
   4. Fukase K.,
   5. Schromm A. B.,
   6. Seydel U.

   Aggregates Are the Biologically Active Units of Endotoxin. J. Biol. Chem. 2004, 279 (25), 26307–26313.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Eaton J.

    LER: The Challenge of Meeting Regulatory Expectations. PDA Lett. 2015, 51 (10), 22.

    OpenUrl
11. 11.↵
    1. Chen D.,
    2. Wintzingerode F.,
    3. Eaton J.,
    4. Levin J.

    PDA LER Task Force Holds its First Workshop. PDA Lett. 2016, 52 (10), 16–18.

    OpenUrl
12. 12.↵
    1. Chen J.,
    2. Vinther A.

    Low Endotoxin Recovery in Common Biologics Products. Presented at the 2013 PDA Annual Meeting, Orlando, FL, April 2013.
13. 13.↵
    Guidance for Industry. Pyrogen and Endotoxins Testing: Questions and Answers; Food and Drug Administration: Washington, DC, 2012.
14. 14.↵
    1. Hughes P. F.,
    2. Thomas C.,
    3. Suvarna K.,
    4. Chi B.,
    5. Candau-Chacon R.,
    6. Gomez-Broughton C.,
    7. Narasimhan L. R.

    Low Endotoxin Recovery: An FDA Perspective. BioPhrma Asia 2015, 4 (2), 14–25.

    OpenUrl
15. 15.↵
    1. Tsuchiya M.

    Limulus Test and Its Application (in Japanese) J. Antibact. Antifung. Agents 1990, 18, 287–294.

    OpenUrl
16. 16.↵
    1. Roth R. I.,
    2. Panter S. S.,
    3. Zegna A. I.,
    4. Levin J.

    Effects of Iron on Bacterial Endotoxin. J. Endotoxin Res. 1997, 4 (4), 273–278.

    OpenUrl
17. 17.↵
    1. Fujita Y.,
    2. Tokunaga T.,
    3. Kataoka H.

    Saline and Buffers Minimize the Action of Interfering Factors in the Bacterial Endotoxins Test. Anal. Biochem. 2011, 409 (1), 46–53.

    OpenUrlPubMed
18. 18.↵
    1. Bolden J.,
    2. Platco C.,
    3. Dubczak J.,
    4. Cooper J. F.,
    5. McCullough K. Z.

    The Use of Endotoxin as an Analyte in Biopharmaceutical Product Hold-Time Study. United States Pharmacopeia: Stimuli to the Revision Process 41 (5), United States Pharmacopeial Convention, Rockville, MD, 2015.
19. 19.↵
    1. Tsuchiya M.

    Possible Mechanism of Low Endotoxin Recovery. Am. Pharm. Rev. 2014, 17 (7), 18–23.

    OpenUrl
20. 20.↵
    1. Reich J.,
    2. Lang P.,
    3. Grallert H.,
    4. Motschmann H.

    Masking of Endotoxin in Surfactant Samples: Effects on Limulus-based Detection Systems. Biologicals 2016, 44 (5), 417–422.

    OpenUrl
21. 21.↵
    1. Bolden J.,
    2. Warburton R. E.,
    3. Phelan R.,
    4. Murphy M.,
    5. Smith K. R.,
    6. De Felippis M. R.,
    7. Chen D.

    Endotoxin Recovery Using Limulus Amebocyte Lysate (LAL) Assay. Biologicals 2016, 44 (5), 434–440.

    OpenUrl
22. 22.↵
    1. Bolden J.,
    2. Claerbout M. E.,
    3. Miner M. K.,
    4. Murphy M. A.,
    5. Smith K. R.,
    6. Warburton R. E.

    Evidence Against a Bacterial Endotoxin Masking Effect in Biologic Drug Products by Limulus Amebocyte Lysate Detection. PDA J. Pharm. Sci. Technol. 2014, 68 (5), 472–477.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Dubczak J. A.

    Comparative In-Vitro and In-Vivo Low Endotoxin Recovery (LER) Assessment. Presented at the PDA 9th Annual Global Conference on Pharmaceutical Microbiology, Bethesda, MD, October 2014.